Product Overview
Structure
Active substance :
Panavir® (Solanum tuberosum shoot polysaccharides) 0.002 g;
Excipients:
glycerol - 30 g;
macrogol 4000 - 15 g;
macrogol 400 - 38 g;
ethanol 95% - 1 g;
sodium hydroxide - 0.4 g;
lanthanum nitrate hexahydrate - 2.2 g;
water - up to 100 g;
pharmachologic effect
Panavir ® - purified extract of the shoots of the plant Solanum tuberosum; the main active ingredient is hexose glycoside, consisting of glucose, rhamnose, arabinose, mannose, xylose, galactose, uronic acids.
Panavir ® is an antiviral and immunomodulating agent. It increases the nonspecific resistance of the body to various infections and promotes the induction of interferons alpha and gamma by white blood cells.
In therapeutic doses, the drug is well tolerated.
Tests have shown the absence of mutagenic, teratogenic, carcinogenic, allergenic and embryotoxic effects. In preclinical studies in laboratory animals, a negative effect on the reproductive function and development of the fetus has not been established.
It has anti-inflammatory properties in experimental models of exudative edema, chronic proliferative inflammation and in the pseudo-allergic inflammatory reaction test for concanavalin A.
An analgesic effect is shown on models of neurogenic pain and pain caused by the inflammatory process and thermal irritation.
It has an antipyretic effect.
The model of parkinsonism syndrome caused by systemic administration of neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine shows neuroprotective properties.
It has the ability to improve the functions of the retina and optic nerve.
It has wound healing properties in the conditions of a model of gastric ulcer.
Indications
Infectious and inflammatory diseases of the skin and / or mucous membranes caused by the herpes simplex virus Herpes simplex types I and II, including genital herpes.
Pregnancy and lactation
Use during pregnancy is only possible if the intended benefit to the mother outweighs the potential risk to the fetus.
If you need to use the drug during lactation, breastfeeding for the period of use of the drug should be discontinued.
Contraindications
- individual intolerance and hypersensitivity to the components of the drug;
- children under 18 years old.
Side effects
Perhaps the occurrence of rapidly passing redness and itching of the skin and / or mucous membranes at the site of application of the gel.
How to take, course of administration and dosage
Outwardly and locally. The gel is applied in a thin layer to the affected areas of the skin and / or mucous membranes 5 times a day.
The duration of treatment is 4–5 days.
The course of treatment can be extended up to 10 days.
Special instructions
It is recommended to begin treatment at the earliest possible stage of the disease, at the first sign (itching, tingling, redness, feeling of tension), in this case, the development of the vesicular stage of the disease can be completely prevented.
Gel Panavir ® is not intended for use in ophthalmology. When applying the gel to the face, avoid contact with eyes.
Release form
gel for local application
